CSA/MMF/steroids versus CSA/AZA/steroids with and without basiliximab in cadaveric kidney transplantation

被引：3

作者：

Boggi, U ^{[1
]}

Vistoli, F ^{[1
]}

Del Chiaro, M ^{[1
]}

Bartolo, TV ^{[1
]}

Rizzo, G ^{[1
]}

Mosca, F ^{[1
]}

机构：

[1] Univ Pisa, UO Nefrol & Trapianti,Div Chirurg Gen & Trapianti, Azienda Ospedaliera Pisana, Dipartimento Oncol Trapianti & Nuove Tecnol, Pisa, Italy

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 7-8期

关键词：

D O I：

10.1016/S0041-1345(01)02361-2

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：3199 / 3200

页数：2

共 10 条

[1]

Cecka J M, 1998, Clin Transpl, P1

[2]

CECKA JM, 1989, CLIN TRANSPLANT, V3, P425

[3] Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy [J].

Danesi, R ;

Mosca, M ;

Boggi, U ;

Mosca, F ;

Del Tacca, M .

MOLECULAR MEDICINE TODAY, 2000, 6 (12) :475-482

[4] Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody [J].

Kahan, BD ;

Rajagopalan, PR ;

Hall, M .

TRANSPLANTATION, 1999, 67 (02) :276-284

[5]

KAHAN BD, 2000, PRINCIPLE PRACTICE R, P89

[6]

KAHAN BD, 2000, PRINCIPLES PRACTICE, P219

[7] Economic analysis of basiliximab in renal transplantation [J].

Keown, PA ;

Balshaw, R ;

Krueger, H ;

Baladi, JF .

TRANSPLANTATION, 2001, 71 (11) :1573-1579

[8] Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].

Nashan, B ;

Moore, R ;

Amlot, P ;

Schmidt, AG ;

Abeywickrama, K ;

Soulillou, JP .

LANCET, 1997, 350 (9086) :1193-1198

[9] Basiliximab [J].

Onrust, SV ;

Wiseman, LR .

DRUGS, 1999, 57 (02) :207-213

[10] An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation [J].

Polsky, D ;

Weinfurt, KP ;

Kaplan, B ;

Kim, J ;

Fastenau, J ;

Schulman, KA .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (05) :1028-1033

← 1 →